Boye, Kristina S.
Eli Lilly (United States)
7 papers on CoChatORCID 0000-0002-5953-5929
Most cited papers
- Verified
The association between sustained HbA1c control and long-term complications among individuals with type 2 diabetes: a retrospective study
Boye, K. S., Thieu, V. T., Lage, M. J., Miller, H., & Paczkowski, R. (2022) · Advances in Therapy
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 99
- Verified
Health utility values associated with diabetic retinopathy
Lloyd, A., Nafees, B., Gavriel, S., Rousculp, M. D., Boye, K. S., & Ahmad, A. (2008) · Diabetic Medicine
Health Systems, Economic Evaluations, Quality of LifeRetinal Diseases and Treatments
Cited by 83
- Verified
Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity
Boye, K. S., Lage, M. J., & Terrell, K. (2020) · Journal of Diabetes and its Complications
Diabetes, Cardiovascular Risks, and LipoproteinsChronic Disease Management Strategies
Cited by 30
- Verified
The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes
Boye, K. S., Ford, J. H., Thieu, V. T., Lage, M. J., & Terrell, K. A. (2023) · Diabetes Therapy
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 26
- Verified
An estimation of the long-term clinical and economic benefits of insulin lispro in type 1 diabetes in the UK
Pratoomsoot, C., Smith, H. T., Kalsekar, A., Boye, K. S., Arellano, J., & Valentine, W. J. (2009) · Diabetic Medicine
Health Systems, Economic Evaluations, Quality of LifeDiabetes Management and Research
Cited by 18
- Verified
Efficacy and Safety of Tirzepatide in Adults With Type 2 Diabetes: A Perspective for Primary Care Providers
Kushner, P., Anderson, J. E., Simon, J., Boye, K. S., Ranta, K., Torcello-Gómez, A., & Levine, J. A. (2023) · Clinical Diabetes
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 14
- Verified
The real‐world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes ( TROPHIES ): Final, 24‐month analysis of time to first significant treatment change, treatment persistence and clinical outcomes
Giorgino, F., Guerci, B., Füchtenbusch, M., Lebrec, J., Boye, K., Orsini Federici, M., Heitmann, E., Dib, A., Yu, M., Sapin, H., et al. (2023) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free